Nucleic acid malaria vaccines. Current status and potential.
Hoffman
S L
SL
Malaria Program Naval Medical Research Institute, Bethesda, Maryland 20889-5607, USA.
Doolan
D L
DL
Sedegah
M
M
Gramzinski
R
R
Wang
H
H
Gowda
K
K
Hobart
P
P
Margalith
M
M
Norman
J
J
Hedstrom
R C
RC
D000595:Amino Acid Sequence; D000818:Animals; D000953:Antigens, Protozoan / Q000235:genetics / Q000276:immunology*; D001029:Aotus trivirgatus; D004274:DNA, Recombinant / Q000008:administration & dosage; D005822:Genetic Vectors / Q000235:genetics; D007273:Injections, Intramuscular; D008288:Malaria / Q000517:prevention & control; D017780:Malaria Vaccines / Q000008:administration & dosage; D051379:Mice; D008807:Mice, Inbred BALB C; D008815:Mice, Inbred Strains; D008969:Molecular Sequence Data; D010961:Plasmodium / Q000235:genetics / Q000254:growth & development / Q000276:immunology*; D010967:Plasmodium yoelii / Q000276:immunology; D015800:Protozoan Proteins / Q000235:genetics / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014614:Vaccines, Synthetic / Q000008:administration & dosage
D000953:Antigens, Protozoan; D004274:DNA, Recombinant; D017780:Malaria Vaccines; D015800:Protozoan Proteins; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic; C041595:circumsporozoite protein, Protozoan